
Pharmaceutical R&D Developer
Pfizer Plans to Place the "Pfizer for All" Brand on a Direct-to-Consumer Pharmaceutical Platform. According to a document from the U.S. Patent and Trademark Office, Pfizer filed a trademark application in mid-April for a website and app to provide U.S. patients with medical information, mail-order pharmacy, and telemedicine services under the "Pfizer for All" brand. (Jiemian)Original link